ISDA

Deposition Date 2013-06-10

Release Date 2013-07-03

Last Version Date 2024-10-30

Entry Detail

PDB ID:

4L52

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}piperidin-1-yl)ethan-1-one bound to TAK1-TAB1

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.54 Å

R-Value Free:

0.22

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

I 2 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera
Gene (Uniprot):MAP3K7, TAB1
Chain IDs:A
Chain Length:307
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:O43318,Q15750 Pfam ID:PF07714

Ligand Molecules

1UL

Primary Citation

Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1.

Hornberger, K.R, Berger, D.M, Crew, A.P, Dong, H, Kleinberg, A, Li, A.H, Medeiros, M.R, Mulvihill, M.J, Siu, K, Tarrant, J, Wang, J, Weng, F, Wilde, V.L, Albertella, M, Bittner, M, Cooke, A, Gray, M.J, Maresca, P, May, E, Meyn, P, Peick, W, Romashko, D, Tanowitz, M, Tokar, B.Show

Bioorg.Med.Chem.Lett. 23 4517 4522 (2013)

PMID: 23850198 DOI: 10.1016/j.bmcl.2013.06.053

Abstact

The discovery and potency optimization of a series of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1 is described. Micromolar hits taken from high-throughput screening were optimized for biochemical and cellular mechanistic potency to ~10nM, as exemplified by compound 12az. Application of structure-based drug design aided by co-crystal structures of TAK1 with inhibitors significantly shortened the number of iterations required for the optimization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures